Gene therapy for cystic fibrosis: challenges and future directions
about
Recombinant GABA(C) receptors expressed in rat hippocampal neurons after infection with an adenovirus containing the human rho1 subunitEngineering viral vectors to subvert the airway defense response.Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression.Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers.Adenovirus-mediated gene expression in vivo is enhanced by the antiapoptotic bcl-2 gene.Immune responses to adenovirus and adeno-associated virus in humans.Nebulisation of receptor-targeted nanocomplexes for gene delivery to the airway epithelium.Differential sensitivity of normal and cystic fibrosis airway epithelial cells to epinephrine.Gene transfer by guanidinium-cholesterol cationic lipids into airway epithelial cells in vitro and in vivoDisrupted adenovirus-based vaccines against small addictive molecules circumvent anti-adenovirus immunity.Gene delivery to the airwayAnimal models of human disease for gene therapyEffect of adenovector-mediated gene transfer of keratinocyte growth factor on the proliferation of alveolar type II cells in vitro and in vivo.The innate immune system in cystic fibrosis lung diseaseGene therapy, early promises, subsequent problems, and recent breakthroughs.Adenovirus-mediated expression of keratinocyte growth factor promotes secondary flap necrotic wound healing in an extended animal model.Distribution of DNA and alginate in purulent cystic fibrosis sputum: implications to pulmonary targeting strategies.Towards a gene therapy for cystic fibrosis lung disease.IL-4 gene transfer to the small bowel serosa leads to intestinal inflammation and smooth muscle hyperresponsiveness.
P2860
Q28346092-5A897DD7-60B4-4F7F-A54A-FE3C84ECAC92Q33643006-9A969D57-B750-4149-8EE3-91B9F10C58C2Q33782516-FCC35594-7BCF-444C-899F-1676F5855A51Q33782809-2F22949C-2883-4FD1-86DD-5EEA376129BDQ33818043-68334442-5B51-492A-BE09-8222F28F0FA4Q33874473-47599705-0089-4D83-9533-C7082944AA15Q34064665-6A75C3A2-61FB-49AC-AFCC-7E2C5C412731Q35041465-DF06C9FC-9F7F-4513-9965-D05680D3DFA7Q36018924-BCD2CD46-3DBB-44C5-A326-4ABB7FDEE8D9Q36562614-306D9581-85EE-43C1-8C65-89C2EB7F5DE1Q37182894-2DB52882-84D6-471C-B3AA-F77CB7672237Q37352252-D3928A2A-028B-4A76-8D25-244EC62C913EQ40844650-91323B73-BDFD-4BBC-90D1-7F6D44C8A9C4Q40848578-48FD654A-89A8-470A-92DC-492E8F94102DQ41807910-0B3A3091-AF60-483D-A16E-A275A0DA3983Q42276479-78D6C958-C3CE-455D-B3C0-FC1471116C0AQ45880451-74CA7AC6-2AEA-441B-9623-AA5CDEFFEA3AQ45884587-FBC4F8AA-9A18-4A9E-A3A3-C472C0DB0F78Q53578205-C5700152-FACB-437E-8139-BC94F42EA658
P2860
Gene therapy for cystic fibrosis: challenges and future directions
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Gene therapy for cystic fibrosis: challenges and future directions
@ast
Gene therapy for cystic fibrosis: challenges and future directions
@en
type
label
Gene therapy for cystic fibrosis: challenges and future directions
@ast
Gene therapy for cystic fibrosis: challenges and future directions
@en
prefLabel
Gene therapy for cystic fibrosis: challenges and future directions
@ast
Gene therapy for cystic fibrosis: challenges and future directions
@en
P2860
P356
P1476
Gene therapy for cystic fibrosis: challenges and future directions
@en
P2093
P2860
P304
P356
10.1172/JCI118318
P407
P577
1995-12-01T00:00:00Z